To understand miRNA behaviour in this context, Shibuya et al. established a mouse model of BC-patient-derived tumour xenografts in which cancer stem cell (CSC) marker CD44+ cancer cells metastasised in the liver. This evidence concerns the gene CD44 and cancer.